OXYGENE
LIVE

Serial Number

79280749

Owner

NOVASEP PROCESS

Attorney

Monte L. Falcoff/Jessica S. Sachs

Filing Date

Jan 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

OXYGENE Trademark

Serial Number: 79280749 • Registration: 6541534

OXYGENE is a trademark filed by NOVASEP PROCESS on January 15, 2020. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NOVASEP PROCESS (10 trademarks)

BOULEVARD DE LA MOSELLE - SITE EIFFEL
POMPEY 54340 , FR

Entity Type: 99

HENOGEN (2 trademarks)

Rue Des Professeurs Jeener et Brachet 12
B-6041 Gosselies , BE

Entity Type: 99

Trademark Details

Filing Date

January 15, 2020

Registration Date

November 2, 2021

Published for Opposition

August 17, 2021

Goods & Services

Supply in the nature of custom manufacture of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing for others of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production in the nature of custom manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents

Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
May 4, 2024 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 15, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 21, 2022 FICS
FINAL DISPOSITION PROCESSED
Apr 21, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 2, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 2, 2021 R.PR
ASSIGNED TO EXAMINER
Aug 23, 2021 DOCK
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 17, 2021 NPUB
PUBLISHED FOR OPPOSITION
Aug 17, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Aug 14, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 28, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 28, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 28, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 13, 2021 CRFA
ASSIGNED TO LIE
Jul 9, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 25, 2021 ERSI
CHANGE OF OWNER RECEIVED FROM IB
May 10, 2021 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Apr 9, 2021 NREP
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Apr 6, 2021 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 3, 2021 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Mar 5, 2021 NREP
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 26, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 26, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jan 26, 2021 CNSL
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 19, 2021 ERFR
EX PARTE APPEAL-INSTITUTED
Jan 19, 2021 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Jan 19, 2021 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Jan 19, 2021 EXAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 26, 2020 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 26, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 26, 2020 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 20, 2020 GNFN
FINAL REFUSAL E-MAILED
Jul 20, 2020 GNFR
FINAL REFUSAL WRITTEN
Jul 20, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 14, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2020 TROA
REFUSAL PROCESSED BY IB
May 15, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Apr 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 11, 2020 RFCR
NON-FINAL ACTION WRITTEN
Apr 10, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 1, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 17, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 13, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 12, 2020 REPR